The TUNEL assay also revealed that CHRNA5 silencing augmented the apoptosis of HCC cells induced by sorafenib, whereas CHRAN5 overexpression attenuated the apoptosis of HCC cells induced by sorafenib (Figure 7F,G). The gene discussed is CHRNA5; the disease is hepatocellular carcinoma.